Jardine Matheson to Acquire Australia's I-MED for $2.4 Billion Enterprise Value

Jardine Matheson Holdings has agreed to acquire Australian medical imaging company I-MED at an enterprise value of $2.4 billion, as part of its growth strategy in the healthcare sector. The deal is seen as part of Jardine Matheson's goal to expand its presence in healthcare services. I-MED is a major player in radiology and medical imaging services in Australia. The acquisition reflects Jardine Matheson's aim to diversify and strengthen its healthcare investments in the Asia-Pacific region. Under the financial terms of the agreement, Jardine Matheson will purchase I-MED's shares for cash. The transaction is expected to close in the first half of 2024, pending regulatory approvals. With this acquisition, Jardine Matheson will expand its healthcare portfolio, while I-MED's existing management team will continue to run the company. The deal is viewed as a strategic move for both parties. This is not investment advice.